36206930|t|Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress.
36206930|a|Increasing evidence suggests that abnormal cerebral glucose metabolism is largely present in Alzheimer's disease (AD). The brain utilizes glucose as its main energy source and a decline in its metabolism directly reflects on brain function. Weighing on recent evidence, here we systematically assessed the aberrant glucose metabolism associated with amyloid beta and phosphorylated tau accumulation in AD brain. Interlink between insulin signaling and AD highlighted the involvement of the IRS/PI3K/Akt/AMPK signaling, and GLUTs in the disease progression. While shedding light on the mitochondrial dysfunction in the defective glucose metabolism, we further assessed functional consequences of AGEs (advanced glycation end products) accumulation, polyol activation, and other contributing factors including terminal respiration, ROS (reactive oxygen species), mitochondrial permeability, PINK1/parkin defects, lysosome-mitochondrial crosstalk, and autophagy/mitophagy. Combined with the classic plaque and tangle pathologies, glucose hypometabolism with acquired insulin resistance and mitochondrial dysfunction potentiate these factors to exacerbate AD pathology. To this end, we further reviewed AD and DM (diabetes mellitus) crosstalk in disease progression. Taken together, the present work discusses the emerging role of altered glucose metabolism, contributing impact of insulin signaling, and mitochondrial dysfunction in the defective cerebral glucose utilization in AD.
36206930	8	26	glucose metabolism	Chemical	-
36206930	30	49	Alzheimer's disease	Disease	MESH:D000544
36206930	59	84	mitochondrial dysfunction	Disease	MESH:D028361
36206930	159	177	glucose metabolism	Chemical	-
36206930	200	219	Alzheimer's disease	Disease	MESH:D000544
36206930	221	223	AD	Disease	MESH:D000544
36206930	245	252	glucose	Chemical	MESH:D005947
36206930	422	440	glucose metabolism	Chemical	-
36206930	457	469	amyloid beta	Gene	351
36206930	489	492	tau	Gene	4137
36206930	509	511	AD	Disease	MESH:D000544
36206930	537	544	insulin	Gene	3630
36206930	559	561	AD	Disease	MESH:D000544
36206930	597	600	IRS	Gene	3376
36206930	606	609	Akt	Gene	207
36206930	610	614	AMPK	Gene	5564
36206930	692	717	mitochondrial dysfunction	Disease	MESH:D028361
36206930	735	753	glucose metabolism	Chemical	-
36206930	855	861	polyol	Chemical	MESH:C024617
36206930	937	940	ROS	Chemical	MESH:D017382
36206930	942	965	reactive oxygen species	Chemical	MESH:D017382
36206930	996	1001	PINK1	Gene	65018
36206930	1002	1008	parkin	Gene	5071
36206930	1134	1156	glucose hypometabolism	Disease	MESH:D018149
36206930	1171	1189	insulin resistance	Disease	MESH:D007333
36206930	1194	1219	mitochondrial dysfunction	Disease	MESH:D028361
36206930	1259	1261	AD	Disease	MESH:D000544
36206930	1306	1308	AD	Disease	MESH:D000544
36206930	1313	1315	DM	Disease	MESH:D003920
36206930	1317	1334	diabetes mellitus	Disease	MESH:D003920
36206930	1442	1460	glucose metabolism	Chemical	-
36206930	1485	1492	insulin	Gene	3630
36206930	1508	1533	mitochondrial dysfunction	Disease	MESH:D028361
36206930	1560	1567	glucose	Chemical	MESH:D005947
36206930	1583	1585	AD	Disease	MESH:D000544
36206930	Association	MESH:D000544	4137
36206930	Association	MESH:D000544	3630
36206930	Association	3376	3630
36206930	Association	MESH:D000544	5564
36206930	Association	MESH:D000544	207
36206930	Association	MESH:D005947	3630
36206930	Association	MESH:D005947	MESH:D028361
36206930	Association	MESH:D000544	3376
36206930	Association	MESH:D000544	351
36206930	Association	MESH:D005947	MESH:D000544

